Modeling how proteins bind to DNA
Quantitative Modeling of Transcription Factor-DNA Binding
This study is looking at how certain proteins that control gene activity attach to DNA, and it hopes to create models that can predict how these proteins work, which could help us find new ways to treat conditions related to gene regulation.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-10650775 on NIH RePORTER |
What this research studies
This research investigates how transcription factors, which are proteins that regulate gene expression, bind to specific sites on DNA. It aims to develop quantitative models that predict the binding behavior of these proteins by considering various factors such as DNA structure, chromatin accessibility, and the presence of other cellular components. By understanding these interactions better, the research seeks to clarify how genes are turned on or off in different cellular contexts. Patients may benefit from insights gained into gene regulation that could lead to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with genetic conditions influenced by transcription factor activity.
Not a fit: Patients with conditions unrelated to gene regulation or transcription factor binding may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of gene regulation, potentially leading to novel treatments for genetic disorders.
How similar studies have performed: Other research has shown success in understanding protein-DNA interactions, but this approach aims to provide a more comprehensive quantitative model, making it a novel contribution to the field.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Rohs, Remo — University of Southern California
- Study coordinator: Rohs, Remo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.